Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

BUY
$40.65 - $59.54 $813,000 - $1.19 Million
20,000 New
20,000 $940,000
Q2 2021

Aug 11, 2021

SELL
$54.88 - $79.29 $1.18 Million - $1.7 Million
-21,500 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$70.65 - $96.76 $1.52 Million - $2.08 Million
21,500 New
21,500 $1.61 Million
Q3 2020

Dec 01, 2020

SELL
$41.13 - $62.45 $1.55 Million - $2.35 Million
-37,600 Closed
0 $0
Q1 2020

May 18, 2020

SELL
$26.15 - $77.24 $99,370 - $293,512
-3,800 Reduced 9.18%
37,600 $1.08 Million
Q4 2019

May 18, 2020

BUY
$60.18 - $154.77 $1.53 Million - $3.93 Million
25,400 Added 158.75%
41,400 $2.98 Million
Q3 2019

Nov 14, 2019

SELL
$140.29 - $189.96 $2.52 Million - $3.42 Million
-17,996 Reduced 52.94%
16,000 $2.25 Million
Q1 2019

May 14, 2019

BUY
$89.33 - $163.65 $1.61 Million - $2.95 Million
18,000 Added 112.53%
33,996 $5.41 Million
Q3 2018

Nov 14, 2018

SELL
$138.11 - $169.04 $684,611 - $837,931
-4,957 Reduced 23.66%
15,996 $1.73 Million
Q3 2018

Nov 13, 2018

SELL
$138.11 - $169.04 $3.04 Million - $3.73 Million
-22,043 Reduced 51.27%
20,953 $809,000
Q2 2018

Aug 13, 2018

SELL
$140.36 - $175.76 $3.86 Million - $4.83 Million
-27,500 Reduced 39.01%
42,996 $6.73 Million
Q1 2018

May 15, 2018

BUY
$152.15 - $192.33 $2.89 Million - $3.65 Million
19,000 Added 36.9%
70,496 $11.3 Million
Q4 2017

Mar 02, 2018

BUY
$60.72 - $167.34 $2.09 Million - $5.77 Million
34,500 Added 202.99%
51,496 $8.48 Million
Q4 2016

Mar 02, 2018

BUY
N/A
16,996
16,996 $867,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $326M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track International Biotechnology Trust PLC Portfolio

Follow International Biotechnology Trust PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

News

Stay updated on International Biotechnology Trust PLC with notifications on news.